STANLEY T CROOKE
CIK 897667 · Exec Chairman of the Board · last filed 2021-01-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$26.52M
Companies
3
Total Filings
113
Lifetime Open-Market Net
-$90.12M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | Exec Chairman of the Board | 496,412 | $53.41 | $26.52M | -$50.31M | 51 | 2021-01-28 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | Chairman and CEO | 32,776 | — | — | -$42.81M | 60 | 2015-10-23 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 58,746 | $8.16 | $479.4K | $3.00M | 2 | 2012-11-07 |
Recent Filings · Page 6 of 12
113 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-04 | IONS | Mixed | — | -$559.4K | EDGAR |
| 2015-10-23 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$1.46M | EDGAR |
| 2015-07-08 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$284.8K | EDGAR |
| 2015-07-02 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$288.3K | EDGAR |
| 2015-04-08 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$1.16M | EDGAR |
| 2015-04-06 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$1.10M | EDGAR |
| 2015-01-29 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$680.3K | EDGAR |
| 2015-01-20 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +8,371 | -$615.3K | EDGAR |
| 2015-01-13 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$687.3K | EDGAR |
| 2015-01-08 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$1.23M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.